Your browser doesn't support javascript.
loading
Comparison of lumen-apposing metal stents versus endoscopic balloon dilation for the management of benign colorectal anastomotic strictures.
Kankotia, Ravi J; Kwon, Richard S; Philips, George M; Regenbogen, Scott E; Zacur, George M; Wamsteker, Erik-Jan; Schulman, Allison R; Machicado, Jorge D.
  • Kankotia RJ; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Kwon RS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Philips GM; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Regenbogen SE; Division of Colorectal Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Zacur GM; Division of Pediatric Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.
  • Wamsteker EJ; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Schulman AR; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Machicado JD; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: machicad@med.umich.edu.
Gastrointest Endosc ; 100(1): 136-139.e3, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38462058
ABSTRACT
BACKGROUND AND

AIMS:

Limited data exist evaluating lumen-apposing metal stents (LAMSs) with endoscopic balloon dilation (EBD) for the treatment of benign colorectal anastomotic strictures (BCASs). This study compares outcomes of both interventions.

METHODS:

Patients with left-sided BCAS treated with LAMSs versus EBD were identified retrospectively. The primary outcome was a composite of crossover to another intervention to achieve clinical success or recurrence requiring reintervention.

RESULTS:

Twenty-nine patients (11 LAMS and 18 EBD) were identified with longer follow-up in the EBD group (734 vs 142 days; P = .003). No significant differences were found in the composite outcome, technical success, clinical success, or components of composite outcome. With LAMS, there was a nonsignificant trend toward fewer procedures (2.4 vs 3.3; P = .06) and adverse events (0% vs 16.7%; P = .26).

CONCLUSIONS:

LAMS appears to be as effective as EBD for the treatment of BCAS but may require fewer procedures and may be safer than EBD.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anastomosis Quirúrgica / Stents / Colonoscopía / Dilatación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anastomosis Quirúrgica / Stents / Colonoscopía / Dilatación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article